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Background: Reducing inappropriate antibiotic prescribing in primary care is a public health priority.
Objectives: We hypothesized that a subset of patients account for the majority of antibiotic prescriptions in pri-
mary care. We investigated the relationship between the total amount of antibiotics prescribed, individual-level
antibiotic use and comorbidity.
Methods: This was a cohort study using electronic health records from 1 948 390 adults registered with 385 pri-
mary care practices in the UK in 2011–13. We estimated the average number of antibiotic prescriptions per pa-
tient and the association between prescribing and comorbidity. We modelled the impact on total prescribing of
reducing antibiotic use in those prescribed antibiotics most frequently.
Results: On average 30.1% (586 194/1 948 390) of patients were prescribed at least one antibiotic per year. Nine
percent (174 602/1 948 390) of patients were prescribed 53% (2 091 496/3 922 732) of the total amount of anti-
biotics, each of whom received at least five antibiotic prescriptions over 3 years. The presence of any comorbidity
increased the prescribing rate by 44% [adjusted incidence rate ratio (IRR) 1.44, 95% CI 1.43–1.45]; rates of pre-
scribing to women exceeded those in men by 62% (adjusted IRR 1.62, 95% CI 1.62–1.63).
Conclusions: Half of antibiotics prescribed to adults in primary care were for ,10% of patients. Efforts to tackle
antimicrobial resistance should consider the impact of this on total prescribing.
Introduction
Reducing inappropriate antimicrobial prescribing is fundamental
to national and international efforts to halt the emergence of drug
resistance.1–3 In Europe .80% of antimicrobials are prescribed in
the community,4 highlighting the need to reduce antimicrobial use
in primary care.
Rates of antibiotic prescribing have been shown to vary widely
between practices in primary care,5,6 with prescribing rates in the
UK slightly less than the EU average.4 This has been interpreted as
an opportunity to improve prescribing quality.7 In England, finan-
cial targets have been set to reduce total antibiotic prescribing and
the use of broad-spectrum antibiotics in primary care by 2015/16,
placing the onus firmly on general practitioners.7,8 However, the
extent to which prescribing variation is driven by the behavioural,
clinical and demographic characteristics of each individual patient
remains uncertain.9
Using data from The Health Improvement Network (THIN) UK
primary care database, we set out to measure variation in the rates
of antibiotic prescribing between individuals and to investigate the
relationship between individual-level antibiotic prescribing and
age, gender and comorbidity, while accounting for variation in pre-
scribing rates between general practices. We modelled the theor-
etical impact on total antibiotic prescribing of reducing antibiotic
use in patients who are prescribed antibiotics frequently by calcu-
lating population-attributable fractions.
Methods
Ethics
The programme of anonymized data provision for researchers using THIN
was approved in 2002. This study was approved by the scientific review
committee, reference 15THIN074.
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Description of the dataset
THIN is a large primary care database comprising electronic medical re-
cords from more than 12 million patients across the UK.10 In the UK, 98% of
the population is registered with a general practitioner, who acts as the
gatekeeper to specialist services and provides advice, treatment and pre-
scriptions.11 Practices contributing to the THIN scheme of data collection
enter demographic and clinical data every time a consultation takes place,
generating a longitudinal record. Symptoms, diagnoses, treatments and re-
ferrals are recorded using a hierarchical system of.100 000 Read codes.12
Prescriptions are recorded by using Multilex (www.fdbhealth.co.uk/solu
tions/multilex) drug codes, which link each drug formulation to the British
National Formulary (www.bnf.org), a compendium of drugs arranged by
system into 15 chapters. Estimates of social deprivation are based on the
Townsend score, a composite measure derived from levels of unemploy-
ment, car ownership, household overcrowding and housing tenure linked
to the individual’s postcode. The THIN dataset is broadly representative of
the UK population,13 with prescription and consultation rates that are com-
parable to national statistics and external data sources.14 The adequacy of
death recording is assessed by comparing mortality rates recorded by the
practice with national age and sex-standardized mortality rates.15 Thus we
included data from when practices met the acceptable mortality recording
criteria, and as we used data from 2011 to 2013 all practices were already
fully computerized.16
Clinical definitions and statistical analysis
Patients aged between 18 and 100 years were eligible for inclusion pro-
vided they had a valid record for date of birth, gender and deprivation quin-
tile. Patients entered the cohort on 1 January 2011 and exited the cohort
on 31 December 2013. Only patients who were registered for the whole
3 year period were included in the study.
An antibiotic prescription was defined as prescription of any drug in
chapter 5.1 (Antibacterial drugs) of the British National Formulary, exclud-
ing anti-TB and anti-leprotic drugs, metronidazole and tinidazole because
we were primarily interested in drugs prescribed for common infections,
such as respiratory, urinary tract or skin infections. We developed a list of
comorbid conditions that might influence the general practitioner’s deci-
sion to prescribe an antibiotic, based on national guidance on the manage-
ment of common infections in primary care.17 To identify patients with
coronary artery disease, COPD, chronic kidney disease, stroke, heart failure
or peripheral arterial disease recorded before 31 December 2011, we de-
veloped Read code lists based on the definitions used in the Quality and
Outcomes Framework (QOF).18 We defined coronary artery disease as a
QOF-defined record for secondary prevention of coronary artery disease to
exclude patients who only had risk factors for coronary artery disease. We
also identified individuals with asthma, high BMI and smoking. We simpli-
fied the QOF-based definition for asthma (see the code lists available as
Supplementary data at JAC Online) because we were interested in a sensi-
tive rather than specific definition of comorbidity. We defined patients as
obese if they had at least one record of BMI.30 kg/m2 in the 5 years before
31 December 2011, on the assumption that the majority of obese patients
fail to achieve sustained reductions in weight. Smoking use was categorized
into a binary variable by defining anyone with a record of having smoked
during the follow-up period, or having smoked prior to the follow-up period
with no record of having stopped as a smoker, and anyone else as a non-
smoker. Age was grouped as a categorical variable reflecting the patterns
of antibiotic use in different age groups. We excluded children and did not
collect information on prescriptions of immunosuppressive drugs because
our analysis focused on the relationship between prescribing and
comorbidity.
To obtain a more precise assessment of the average rate of antibiotic
prescribing per patient, we used prescribing data for a 3 year period. We
calculated the average rate of antibiotic prescribing per 3 years, and the
equivalent annual rate, counting the total number of antibiotics
prescribed per patient between 1 January 2011 and 31 December 2013.
The denominator was the total number of person-years contributed by pa-
tients in the cohort over the same time period. Variation in per patient anti-
biotic prescribing was displayed graphically. We fitted negative binomial
regression models to estimate the average number of antibiotics prescribed
per patient, by age group, sex and Townsend score. To estimate the inci-
dence rate ratios (IRRs) we generated a fully adjusted model with age, sex,
Townsend score and comorbidity status (as a binary variable) and included
a random effect to account for variation between practices. We used the
likelihood ratio test to determine whether there was an interaction be-
tween age and sex in the fully adjusted model.
In addition, for each comorbidity and smoking, a negative binomial re-
gression model was fitted taking antibiotic prescription rates over the
3 year period as the primary outcome, with age, sex, Townsend score and
any significant interaction term as model covariates, including practice as a
random effect. Multi-morbidity was defined as the presence of at least two
of the comorbidities listed above.
To illustrate the potential population impact on total antibiotic prescrib-
ing of reducing antibiotic use in groups of patients who are frequently pre-
scribed antibiotics, we calculated population-attributable fractions for
patients with at least one comorbidity, for patients with multi-morbidity
and for smokers. For smokers and patients with comorbidity or multi-
morbidity we compared the adjusted rate of antibiotic prescribing relative
to the rate of prescribing in the general population. We calculated popula-
tion attributable fractions using the method described by Kleinbaum et al.19
(Table S1, available as Supplementary data at JACOnline).
Results
We included data from 1 948 390 adult patients who were regis-
tered with 385 general practices, representing 3 922 732 antibiotic
prescriptions. Forty-nine percent were male, 35% had comorbidity
and 20% were smokers. On average, 30.1% of patients were pre-
scribed at least one antibiotic per year (580 038 patients in 2011,
598 202 patients in 2012 and 580 843 patients in 2013). Over the
3 year study period, 46.1% (899 160/1 948 390) of patients
were not prescribed any antibiotics (Figure 1). Of the antibiotics,
53.3% were prescribed to 9% of registered patients (Table 1),
each of whom was prescribed at least five antibiotics during the
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Figure 1. Frequency of antibiotic use per patient over a 3 year period
(2011–13). Forty-six percent of patients were not prescribed an antibi-
otic, but 7% received at least seven antibiotic prescriptions over the
same time period.
Shallcross et al.
2 of 7
study period. Almost 10% (390 008/3 922 732) of antibiotics were
prescribed to ,0.5% (8549/1 948 390) of patients, each of whom
received at least 30 prescriptions during the study period.
The prescribing rate was 2.01 (95% CI 2.01–2.02) antibiotics per
3 years, equivalent to an average rate of 0.67 (95% CI 0.67–0.67)
prescriptions per person-year. There was an interaction between
age and gender so all subsequent analyses were stratified by gen-
der (P,0.0001). The rate of prescribing adjusted for age, social de-
privation and comorbidity was 62% higher in women compared
with men (adjusted IRR 1.62, 95% CI 1.62–1.63). Overall, the rates
of antibiotic prescribing increased with increasing age, but this as-
sociation was more marked in men compared with women
(Table 2). Rates of prescribing to the most socially deprived individ-
uals exceeded rates in the least deprived by 10% in men (adjusted
IRR 1.10, 95% CI 1.09–1.12) and 19% in women (adjusted IRR
1.19, 95% CI 1.18–1.20) (Table 2).
The presence of any of the specified comorbidities increased
the rate of antibiotic prescribing by more than one-third
(Tables 3 and 4). The rate of antibiotic prescribing to patients with
COPD was 3-fold greater than the rates of antibiotic prescribing for
the general population (adjusted IRR 3.01, 95% CI 2.98–3.04).
Individuals with heart failure, asthma or peripheral arterial disease
were prescribed 53%–69% more antibiotics than individuals with-
out these conditions. Compared with the general population, dia-
betics and individuals with coronary artery disease were prescribed
47% more antibiotics. Obesity, stroke and chronic kidney disease
were all associated with more than a one-third increase in rates of
antibiotic prescribing compared with individuals without these
conditions.
Amongst the 65% of patients without comorbidity, 52.3%
(665 136/1 271 513) were not prescribed any antibiotics during the
study. The percentage of patients receiving a prescription more
frequently than twice per year was 4.2% (53 028/1 271 513) on
average (Figure 2). By contrast, 25.3% (48 457/191 709) of patients
with multi-morbidity were not prescribed any antibiotics during
the 3 year study and 20.0% (38 417/191 709) were prescribed
antibiotics more frequently than twice per year (Figure S1).
The rate of antibiotic prescribing to smokers exceeded that to
non-smokers by 13% (adjusted IRR 1.13, 95% CI 1.12–1.13).
During the study period 45.0% (178 022/395 824) of smokers were
not prescribed any antibiotics at all and 6.0% (23 816/395 824)
were prescribed antibiotics more frequently than twice per year.
At a population level, if the rate of antibiotic prescribing could
be reduced in patients with multi-morbidity to the rate seen in the
general population, the maximum reduction in total prescribing
would be an estimated 7%. Similarly, if prescribing rates were
reduced in patients with comorbidity to the rate seen in the gen-
eral population, the maximum decrease in total antibiotic prescrib-
ing would be 16% over 3 years. Finally, if the rate of prescribing to
Table 1. Frequency of antibiotic prescribing in primary care and relation-
ship to total antibiotic use
Antibiotics
prescribed per
3 years
Number of patients
(cumulative %)
Number of antibiotic
prescriptions (cumulative %)
Total 1 948 390 3 922 732
.30 8549 (0.4) 390 008 (9.9)
16–30 23 418 (1.6) 486 162 (22.3)
11–15 30 461 (3.2) 383 589 (32.1)
7–10 73 842 (7.0) 601 745 (47.5)
6 38 332 (9.0) 229 992 (53.3)
5 55 898 (11.8) 279 490 (60.4)
4 83 624 (16.1) 334 496 (69.0)
3 131 781 (22.9) 395 343 (70.1)
2 218 582 (34.1) 437 164 (90.2)
1 384 743 (53.9) 384 743 (100.0)
0 899 160 (100.0) 0
Table 2. Relationship between social and demographic characteristics and antibiotic prescribing
Clinical feature
Number of
patients (%)
Prescribing rate
per 3 years (95% CI)
Unadjusted IRR (95% CI)a Adjusted IRRb (95% CI)
males females males females
Age (years)
18–44 825 266 (42.4) 1.48 (1.47–1.49) 1 1 1 1
45–64 715 494 (36.7) 1.90 (1.89–1.91) 1.50 (1.48–1.51) 1.17 (1.16–1.18) 1.17 (1.17–1.18) 1.01 (1.01–1.02)
65–84 371 860 (19.1) 3.18 (3.16–3.21) 2.82 (2.79–2.85) 1.79 (1.77–1.80) 1.72 (1.71–1.74) 1.32 (1.32–1.33)
.84 35 770 (1.8) 4.51 (4.42–4.60) 4.00 (3.88–4.13) 2.39 (2.35–2.44) 2.26 (2.22–2.31) 1.67 (1.64–1.69)
Social deprivationc
1 (least deprived) 518 734 (26.6) 1.83 (1.82–1.84) 1 1 1 1
2 438 753 (22.5) 1.93 (1.92–1.95) 1.04 (1.03–1.05) 1.06 (1.05–1.07) 1.01 (1.01–1.02) 1.01 (1.02–1.03)
3 410 325 (21.1) 2.03 (2.02–2.05) 1.07 (1.06–1.08) 1.13 (1.12–1.14) 1.04 (1.04–1.05) 1.07 (1.06–1.08)
4 345 464 (17.7) 2.15 (2.14–2.17) 1.10 (1.09–1.12) 1.22 (1.20–1.23) 1.08 (1.07–1.09) 1.12 (1.11–1.13)
5 (most deprived) 235 114 (12.1) 2.32 (2.30–2.34) 1.16 (1.15–1.18) 1.34 (1.32–1.35) 1.10 (1.09-1.12) 1.19 (1.18–1.20)
aInteraction between age and gender so all analyses stratified by gender; P,0.0001 based on the likelihood ratio test.
bIRR adjusted for all other variables in the model and comorbidity.
cQuintile of deprivation.
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smokers could be reduced to the rate seen in the general popula-
tion, total antibiotic prescribing would fall by 2% over 3 years.
Discussion
In this large, individual-level study of antibiotic use and comorbid-
ity amongst patients in primary care, more than half of the total
amount of antibiotics were prescribed to 9% of patients, each of
whom had at least five antibiotics in 3 years. Our results highlight
the importance of high-frequency antibiotic use in a subset of pa-
tients with high rates of comorbidity.
A major strength of this study is the quality and scale of the pa-
tient information recorded in THIN, and the fact that our results
can be generalized to the UK population.13 This was confirmed by
Table 3. Relationship between comorbidities and antibiotic prescribing
Comorbidity
Number of
patients (%)
Prescribing rate per
3 years (95% CI)
Crude IRR
(95% CI)
Adjusted IRR
(95% CI)
Asthma no 1.85 (1.86–1.86) 1 1
yes 216 375 (11.1) 3.28 (3.26–3.30) 1.77 (1.76–1.78) 1.64 (1.63–1.64)
Coronary artery disease no 1.91 (1.91–1.92) 1 1
yes 88 391 (4.5) 4.11 (4.07–4.15) 2.15 (2.12–2.17) 1.47 (1.46–1.48)
Chronic kidney disease no 1.92 (1.91–1.92) 1 1
yes 79 030 (4.1) 4.33 (4.28–4.37) 2.26 (2.23–2.28) 1.34 (1.32–1.35)
COPD no 1.89 (1.88–1.89) 1 1
yes 36 116 (1.9) 8.69 (8.58–8.79) 4.60 (4.53–4.68) 3.01 (2.98–3.04)
Diabetes no 1.91 (1.91–1.92) 1 1
yes 107 378 (5.5) 3.77 (3.74–3.80) 1.97 (1.95–1.99) 1.47 (1.46–1.48)
Heart failure no 1.99 (1.98–1.99) 1 1
yes 14 424 (0.7) 5.47 (5.35–5.59) 2.75 (2.68–2.82) 1.69 (1.66–1.72)
Obesity no 1.82 (1.81–1.82) 1 1
yes 358 929 (18.4) 2.87 (2.86–2.89) 1.58 (1.57–1.59) 1.37 (1.35–1.39)
Peripheral arterial disease no 1.99 (1.99–1.99) 1 1
yes 16 993 (0.9) 4.69 (4.59–4.79) 2.36 (2.30–2.41) 1.53 (1.50–1.55)
Stroke no 1.99 (1.98–1.99) 1 1
yes 22 741 (1.2) 4.41 (4.32–4.50) 2.22 (2.17–2.27) 1.37 (1.35–1.39)
Smoker no 2.01 (2.01–2.02) 1 1
yes 395 824 (20.3) 2.01 (2.00–2.02) 1.00 (0.99–1.01) 1.13 (1.12–1.13)
Comorbidities 0 1 271 513 (65.3) 1.44 (1.44–1.45) 1 1
1 485 168 (24.9) 2.50 (2.49–2.51) 1.73 (1.72–1.74) 1.44 (1.43–1.45)
2 138 725 (7.1) 3.98 (3.95–4.01) 2.76 (2.73–2.78) 1.93 (1.92–1.94)
3 52 984 (2.7) 6.05 (5.98–6.12) 4.19 (4.13–4.24) 2.54 (2.51–2.56)
Table 4. Relationship between antibiotic prescribing and comorbidity
Number of
antibiotics
prescribed
Comorbidity
diabetes
chronic
kidney
disease asthma
coronary
artery
disease
heart
failure
peripheral
arterial
disease
stroke/transient
ischaemic
attack COPD smoking obesity
n % n % n % n % n % n % n % n % n % n %
0 33 188 30.9 21 907 27.7 71 388 33.0 25 473 28.8 3144 21.8 4431 26.1 6749 29.7 3917 10.8 17 8022 45.0 125 146 34.9
1 19 551 18.2 13 771 17.4 40 679 18.8 15 803 17.9 2231 15.5 2850 16.8 3845 16.9 3699 10.2 78 381 19.8 71 013 19.8
2–3 22 705 21.1 17 075 21.6 45 146 20.9 18 852 21.3 3108 21.5 3507 20.6 4676 20.6 6376 17.7 73 035 18.5 76 588 21.3
4–6 15 202 14.2 12 019 15.2 29 301 13.5 12 936 14.6 2414 16.7 2695 15.9 3272 14.4 6839 18.9 38 082 9.6 45 868 12.8
7–10 8006 7.5 6631 8.4 15 277 7.1 7134 8.1 1579 10.9 1577 9.3 1871 8.2 5610 15.5 15 946 4.0 21 370 6.0
11–15 3833 3.6 3194 4.0 6987 3.2 3504 4.0 833 5.8 878 5.2 935 4.1 3865 10.7 6460 1.6 9209 2.6
16–30 3349 3.1 2957 3.7 5615 2.6 3231 3.7 754 5.2 725 4.3 936 4.1 4096 11.3 4579 1.2 7131 2.0
.30 1544 1.4 1476 1.9 1982 0.9 1458 1.6 361 2.5 330 1.9 457 2.0 1714 4.7 1319 0.3 2604 0.7
Total 107 378 100.0 79 030 100.0 216 375 100.0 88 391 100.0 14 424 100.0 16 993 100.0 22 741 100.0 36 116 100.0 395 824 100.0 358 929 100.0
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our estimates of chronic disease prevalence, which were compar-
able to the national QOF dataset for all conditions except asthma
(where we modified the QOF-based definition; see the Methods
section). The limitations of our analysis reflect that the THIN data-
set was devised for clinical management of patients rather than
for the purpose of research, so we lacked sufficient information to
estimate the appropriateness of antibiotic prescribing for patients
with comorbidity. We focused on antibiotic prescribing in adults
because our aim was to estimate the relationship between antibi-
otic use and comorbidity. We used a robust method to identify pa-
tients with chronic illnesses that might influence the general
practitioner’s decision to prescribe,17 but a limitation of our study is
that we did not identify patients with chronic liver or neurological
disease because QOF codes for these conditions have not been de-
veloped. To provide clinically interpretable estimates of antibiotic
use we only included patients who were registered with eligible
general practices for the full 3 year period, which may have intro-
duced selection bias by excluding patients who died or left the
practice, potentially underestimating the association between pre-
scribing and comorbidity. We restricted the diagnosis of comorbid-
ity to patients with a relevant Read code recorded before
31 December 2011 to ensure that patients had sufficient follow-
up time (2 years) to examine the relationship between prescribing
and comorbidity. However, this may have inadvertently led to an
underestimate of the association between prescribing and comor-
bidity as some patients will have developed comorbid conditions
during follow-up. In order to model the maximal theoretical im-
pact of reducing the antibiotic use in patients with comorbidity, we
calculated population-attributable fractions, making the import-
ant assumption that comorbidity is the main driver of prescribing
in these patients. In reality, the drivers of prescribing are multi-
factorial and, although we took account of clustering by practice,
we did not consider the role of individual-level prescriber factors in
our analysis.
The fact that the rates of antibiotic prescribing vary between
general practices is well established,5,6,20 but most studies that
have addressed the reasons for this variation have been ecological,
using practice-level data.21,22 Our estimates of the proportion of
patients who are prescribed at least one antibiotic per year are
comparable to annual antibiotic prevalence estimates derived from
European healthcare data.23 In common with these studies, we re-
port higher rates of prescribing in women and in older age
groups.23,24 A plausible explanation for at least part of the higher
rates of antibiotic prescribing in women is a higher incidence of urin-
ary tract infection, estimated at 0.5–0.7 infections per year in
women,25 and 5–8 infections per 10 000 per year in men.26 Women
and the elderly are also more likely to consult their general practi-
tioner,27 and are therefore more likely to be prescribed antibiotics.
Clearly, for some patients frequent antibiotic use is appropriate
and justified, e.g. to ensure antibiotics are initiated promptly for pa-
tients with bacterial infective exacerbations of COPD through the
use of antibiotic rescue packs, or through the use of prophylactic
antibiotics for recurrent urinary tract infection. Nonetheless, there
is some evidence that even for higher-risk patients, such as smok-
ers or those with comorbidities with acute lower respiratory tract
infection (where pneumonia is not suspected), antibiotic treat-
ment may confer no clinically meaningful benefit.28 In one of the
few studies investigating the individual-level relationship between
comorbidity and antibiotic prescribing, co-existing diabetes and
heart failure were independently associated with prescription of
an antibiotic in patients with COPD.29 In a population-based
Swedish study, patients with comorbidity (Charlson’s index of 3)
were 3-fold more likely to be prescribed antibiotics compared with
individuals without comorbidity. However, this study is likely to
have over-estimated the relationship between antibiotic prescrib-
ing and comorbidity because comorbidity was defined by hospital-
ization, based on a list of ICD-10 codes.20 As many patients with
comorbidities are managed in primary care without recourse to
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Figure 2. Relationship between comorbidity and frequency of antibiotic prescribing per patient, 2011–13.
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hospital, this approach will tend to underestimate the prevalence
of comorbidity in primary care. By contrast, a strength of our ap-
proach is that we used definitions that were specifically designed
for primary care to identify patients with relevant comorbidities.
With regard to smoking, our findings agree with results from a
large multicentre study, identifying the patient’s smoking status
as an independent predictor of the general practitioner’s decision
to prescribe an antibiotic.30 Interestingly, this study found no evi-
dence that increased rates of antibiotic prescribing conferred any
benefit to smokers.30 Whilst few clinicians would question the fact
that patients with diabetes are at increased risk of infection,31
there are a range of other comorbidities, such as cardiovascular
disease or obesity, that may also be considered when making the
clinical decision to prescribe an antibiotic.17 There is a real need for
more granular research studies to advance our understanding of
whether higher rates of antibiotic use in patients with comorbidity
are primarily driven by diagnostic uncertainty, exemplified by the
dilemma of whether to prescribe antibiotics for an infective ex-
acerbation of COPD, or by concerns about an overall increased sus-
ceptibility to infection in patients with comorbidities such as
diabetes. Given the anticipated increases in rates of comorbidity
with an ageing population, disentangling the role of comorbidity in
susceptibility to and outcomes from bacterial infection may be im-
portant in the context of public health initiatives to rationalize anti-
biotic use in primary care.
In the UK national targets have been set to reduce total antibi-
otic prescribing,7 with a focus on primary prevention rather than a
more targeted approach focused on reducing antibiotic prescribing
to those individuals with the highest levels of antibiotic consump-
tion. This has led to reductions in antibiotic consumption but it re-
mains to be seen whether such efforts translate into a reduction in
the incidence of antimicrobial resistance. For example, in a recent
population-based study from Slovenia, a 30% reduction in anti-
microbial prescribing had a variable impact on antimicrobial resist-
ance, leading the authors to conclude that targeted interventions
may be required to truly impact on antimicrobial resistance.32
Patients with frequent antibiotic exposure are likely to be at greatest
risk of antimicrobial resistance, not only through their increased ex-
posure to antibiotics,33 but also because they are more likely to be
admitted to hospital, where they may be exposed to drug-resistant
pathogens.34 In the context of international initiatives to reduce in-
appropriate antibiotic use, it may be important to assess the feasi-
bility of reducing the rate of antibiotic prescribing to patients with
the highest frequency of antibiotic use. Such efforts will require fur-
ther research to characterize the temporal relationship between
antibiotic prescribing and the clinical indication for the prescription.
Data sharing
The data are under licence, but the code lists are provided as
Supplementary data. The data algorithms used in the analysis are
available from the corresponding author.
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